Brief: Matinas Biopharma Announces The Termination Of Mat2203 Partnership Negotiations And Implements Immediate Workforce Reduction

Matinas BioPharma Holdings

31/10/2024 11:22

Oct 31 (Reuters) - Matinas BioPharma Holdings Inc
 MTNB.A :
    * MATINAS BIOPHARMA ANNOUNCES THE TERMINATION OF MAT2203
PARTNERSHIP NEGOTIATIONS AND IMPLEMENTS IMMEDIATE WORKFORCE
REDUCTION
    * MATINAS BIOPHARMA HOLDINGS INC - IMPLEMENTS 80% WORKFORCE
REDUCTION, ELIMINATES 15 POSITIONS
    * MATINAS BIOPHARMA HOLDINGS INC - CHIEF MEDICAL OFFICER,
CHIEF
BUSINESS OFFICER, AND CHIEF TECHNOLOGY OFFICER DEPART
    * MATINAS BIOPHARMA -  INTENDS TO RETAIN ADVISOR TO ASSIST
COMPANY
WITH POTENTIAL ASSET SALE OF MAT2203

Source text:  ID:nGNX4ylPN3 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))